Selective TBK1/IKKi dual inhibitors with anticancer potency
Jijia Li(Xiangya Hospital Central South University), Jun‐Li Luo(Scripps Research Institute)
Cited by 41
Related Papers
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
|Journal of Clinical Investigation|2005|878